Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
The World War II veteran who walked into the hearts of a nation in lockdown as he shuffled up and down his garden to raise money for healthcare workers has died after testing positive for COVID-19.
Pennsylvania entrepreneur Jared Isaacman aims to use the trip to raise $200 million for St. Jude Children's Research Hospital.
Does wearing two masks provide more protection?
Geraldine Barnuevo, , environmental strategies and sustainability senior manager at GM, spoke to Cheddar about what's in store for the automaker following its big pledge to go carbon neutral by 2040.
Johnson & Johnson says its vaccine appears to protect against COVID-19 with just one shot.
Event organizers and other unconventional logistics experts are using their skills to help the nation vaccinate as many people against COVID-19 as possible.
The Heat will use coronavirus-sniffing dogs at AmericanAirlines Arena to screen fans who are coming to their home games.
A new variant of the coronavirus has emerged in the United States.
John Banovetz, chief technology officer at 3M, spoke with Cheddar about how we can better prepare for future pandemics based on lessons learned from COVID.
Employers weigh the pros and cons of potentially mandating workers get the COVID vaccine or incentivizing them to get the shots, a conundrum complicated by legal considerations.
